Andrew H Galligan Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew H Galligan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew H Galligan. Andrew H Galligan is a Director in Diadexus, Inc. ($DDXS) and a Director in OOMA INC ($OOMA) and a Chief Financial Officer in NEVRO CORP ($NVRO).
Address: C/O DIADEXUS, INC. 343 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which Andrew H Galligan is an Insider
Diadexus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew H Galligan: Director
Holdings: 0 shares
Latest Transaction: Aug 12 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEVRO CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Andrew H Galligan: Chief Financial Officer
Holdings: 59,179 shares
Current Value: $5,523,176
Latest Transaction: Jun 08 2020
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OOMA INC
Industry: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
Position of Andrew H Galligan: Director
Holdings: 171,435 shares
Current Value: $1,688,635
Latest Transaction: Jun 05 2020
$OOMA Market Capitalization: $176.28M
$OOMA Previous Close: $9.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew H Galligan
Sentiment: All, DDXS, NVRO, OOMA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2020 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Payment of Exercise | F | 121.53 | 2,311 | 280,856 | 59,179 | 61.5 K to 59.2 K (-3.76 %) |
| Jun 05 2020 | OOMA | OOMA INC | Galligan Andrew H | Director | Grant | A | 0.00 | 10,451 | 0 | 171,435 | 161 K to 171.4 K (+6.49 %) |
| Mar 03 2020 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 8,000 | 28,800 | 33,394 | |
| Mar 03 2020 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 8,000 | 28,800 | 33,394 | |
| Mar 03 2020 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 8,000 | 28,800 | 61,490 | 53.5 K to 61.5 K (+14.96 %) |
| Mar 03 2020 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 8,000 | 28,800 | 61,490 | 53.5 K to 61.5 K (+14.96 %) |
| Jan 10 2020 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 63.23 | 17,718 | 1,120,309 | 0 |